[CAS NO. 356057-34-6]  Darapladib (SB-480848)

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [356057-34-6]

Store
Catalog
SLK-S7520
Brand
Selleck
CAS
356057-34-6

DESCRIPTION [356057-34-6]

Overview

MDLMFCD18251452
Molecular Weight666.77
Molecular FormulaC36H38F4N4O2S
SMILESC(C(N(CC1=CC=C(C=C1)C2=CC=C(C(F)(F)F)C=C2)CCN(CC)CC)=O)N3C4=C(C(=O)N=C3SCC5=CC=C(F)C=C5)CCC4

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM1.4998 mL7.4988 mL14.9977 mL
5 mM0.3000 mL1.4998 mL2.9995 mL
10 mM0.1500 mL0.7499 mL1.4998 mL
50 mM0.0300 mL0.1500 mL0.3000 mL

Description

Darapladib (SB-480848) is a reversible inhibitor with of 0.25 nM. Phase 3.

Targets

Lp-PLA2 [1]
(Cell-free assay)
0.25 nM

In vitro

During the copper catalysed oxidation of human LDL, Darapladib prevents the production of lyso-PtdCho with IC50 of 4 nM and subsequent monocyte chemotaxis with IC50 of 4 nM.


Synonyms

1H-Cyclopentapyrimidine-1-acetamide, N-[2-(diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-N-[[4′-(trifluoromethyl)[1,1′-biphenyl]-4-yl]methyl]-
N-[2-(Diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-N-[[4′-(trifluoromethyl)[1,1′-biphenyl]-4-yl]methyl]-1H-cyclopentapyrimidine-1-acetamide
1-[[[N-[2-(Diethylamino)ethyl]-N-[4-[4-(trifluoromethyl)phenyl]benzyl]amino]carbonyl]methyl]-2-(4-fluorobenzylthio)-5,6-trimethylenepyrimidin-4-one
SB 480848
SB 435445
Darapladib